Page 64 - ITPS-6-2
P. 64

INNOSC Theranostics and
            Pharmacological Sciences                                                    Tryptophan and schizophrenia



               https://doi.org/10.1016/j.bbapap.2016.06.014       pathway metabolomics predicts and provides mechanistic
                                                                  insight into multiple sclerosis progression. Sci Rep, 7: 41473.
            13.  Erhardt S, Schwieler L, Imbeault S,  et al., 2017, The
               kynurenine pathway in schizophrenia and bipolar disorder.      https://doi.org/10.1038/srep41473
               Neuropharmacology, 112: 297–306.
                                                               18.  Agudelo LZ, Femenia T, Orhan F, et al., 2014, Skeletal muscle
               https://doi.org/10.1016/j.neuropharm.2016.05.020   PGC-1α1 modulates kynurenine metabolism and mediates
                                                                  resilience to stress-induced depression. Cell, 159: 33–45.
            14.  Schwarcz R, Pellicciari R, 2002, Manipulation of brain
               kynurenines: Glial targets, neuronal effects, and clinical      https://doi.org/10.1016/j.cell.2014.07.051
               opportunities. J Pharmacol Exp Ther, 303: 1–10.
                                                               19.  Myint AM, Kim YK, 2014, Network beyond IDO in
               https://doi.org/10.1124/jpet.102.034439            psychiatric  disorders:  Revisiting  neurodegeneration
                                                                  hypothesis.  Prog Neuropsychopharmacol Biol Psychiatry,
            15.  Hilmas C, Pereira EF, Alkondon M, et al., 2001, The brain
               metabolite kynurenic acid inhibits alpha7 nicotinic receptor   48: 304–313.
               activity and increases non-alpha7 nicotinic receptor      https://doi.org/10.1016/j.pnpbp.2013.08.008
               expression: Physiopathological implications.  J  Neurosci,   20.  Schwarcz R, Bruno JP,  Muchowski PJ,  et al., 2012,
               21: 7463–7473.
                                                                  Kynurenines in the mammalian brain: When physiology
               https://doi.org/10.1523/jneurosci.21-19-07463.2001  meets pathology. Nat Rev Neurosci, 13: 465–477.
            16.  Stone TW, 2020, Does kynurenic acid act on nicotinic      https://doi.org/10.1038/nrn3257
               receptors? An assessment of the evidence.  J  Neurochem,   21.  Andresasen NC, Black DW, 2009, Introdução à Psiquiatria.
               152: 627–649.
                                                                  Porto Alegre: Artmed.
               https://doi.org/10.1111/jnc.14907
                                                               22.  De Alvarenga PG, de Andrade AG, 2008, Fundamentos em
            17.  Lim CK, Bilgin A, Lovejoy DB,  et al., 2017, Kynurenine   Psiquiatria. São Paulo: Manole.
















































            Volume 6 Issue 2 (2023)                         5                         https://doi.org/10.36922/itps.0435
   59   60   61   62   63   64   65   66